Glycaemic outcomes in adults with type 1 diabetes transitioning towards advanced automated insulin delivery systems - a real-world analysis at a Swiss tertiary centre

被引:1
|
作者
Lehmann, Vera [1 ]
Noti, Franco [1 ]
Laimer, Markus [1 ]
Stettler, Christoph [1 ]
Zuger, Thomas [1 ,2 ]
机构
[1] Univ Bern, Bern Univ Hosp, Inselspital, Dept Diabet Endocrinol Nutr Med & Metab, CH-3010 Bern, Switzerland
[2] Kantonsspital Olten, Dept Diabet Endocrinol & Metab Dis, Olten, Switzerland
关键词
HYBRID CLOSED-LOOP;
D O I
10.57187/s.3501
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AIMS OF THE STUDY: To assess glucose levels in adults with diabetes at a Swiss tertiary hospital when transitioning from insulin delivery with a sensor-augmented pump with (predictive) low-glucose suspend ([P]LGS) to a hybrid-closed loop (HCL) and from a HCL to an advanced hybrid-closed loop (AHCL). METHODS: Continuous glucose monitoring data for 44 adults with type 1 diabetes transitioning from (P)LGS to hybrid-closed loop and from hybrid-closed loop to advanced hybrid-closed loop were analysed, including the percentage of time spent within, below, and above glucose ranges. In addition, a subgroup analysis (n = 14) of individuals undergoing both transitions was performed. RESULTS: The transition from a (P)LGS to a hybrid-closed loop was associated with increased time in range (6.6% [2.6%-12.7%], p <0.001) and decreased time above range (5.6% [2.3%-12.7%], p <0.001). The transition from a hybrid-closed loop to an advanced hybrid-closed loop was associated with increased time in range (1.6% [-0.5%-4.5%], p = 0.046) and decreased time above range (1.5% [-1.8%-5.6%], p = 0.050). Both transitions did not change the time below range. In the subgroup analysis ([P]LGS. HCL. AHCL), the time in range increased from 69.4% (50.3%-79.2%) to 76.5% (65.3%-81.3%) and 78.7% (69.7%-85.8%), respectively (p <0.001). CONCLUSIONS: Glucose levels significantly improved when transitioning from a (P)LGS to a hybrid-closed loop. Glucose levels improved further when switching from a hybrid-closed loop to an advanced hybrid-closed loop. However, the added benefit of an advanced hybrid-closed loop was comparably smaller. This pattern was also reflected in the subgroup analysis.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Impact of Automated Insulin Delivery Systems by Baseline HbA1c in Emerging Adults with Type 1 Diabetes
    Waterman, Lauren A.
    Alonso, Guy T.
    Sakamoto, Casey
    Pyle, Laura
    Forlenza, Gregory P.
    Shah, Viral N.
    Cobry, Erin C.
    DIABETES, 2024, 73
  • [42] Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Adults with Type 1 Diabetes
    Amuedo, Sandra
    Antequera, Maria
    Azriel, Sharona
    DIABETES, 2022, 71
  • [43] Early real-world performance of the Omnipod® 5 automated insulin delivery (AID) system in 9,900 people with type 1 diabetes in Europe
    Wilmot, E. G.
    Biester, T.
    Campbell, F. M.
    Deiss, D.
    Elliott, J.
    Gibb, F.
    Kroeger, J.
    Huyett, L. M.
    Mendez, J. J.
    Hadjiyianni, I.
    Conroy, L. R.
    Ly, T. T.
    DIABETOLOGIA, 2024, 67 : S64 - S65
  • [44] Real-world efficacy and safety of open-source automated insulin delivery for people with type 1 diabetes mellitus: Experience from mainland China
    Zhou, Yongwen
    Lei, Mengyun
    Yang, Daizhi
    Ling, Ping
    Ni, Ying
    Deng, Hongrong
    Xu, Wen
    Yang, Xubin
    Wheeler, Benjamin John
    Weng, Jianping
    Yan, Jinhua
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 218
  • [45] Assessing glycaemic impact of FreeStyle libre monitoring in patients with insulin-treated type 2 diabetes: a retrospective real-world analysis
    Atkinson, Michael
    Williams, David M.
    Crockett, Elin
    Hathaway, Isaac
    Mon, May
    Stephens, Jeffrey W.
    Min, Thinzar
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2025, 24 (01)
  • [46] Transitioning to automated insulin delivery systems in children and young people with type 1 diabetes: impact on insulin requirements, anthropometrics, glucose metrics and user behaviour
    Kohli, A.
    Pemberton, J.
    Uday, S.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 164 - 165
  • [47] Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Multinational Survey of Adults With Type 1 Diabetes
    Schipp, Jasmine
    Hendrieckx, Christel
    Braune, Katarina
    Knoll, Christine
    O'Donnell, Shane
    Ballhausen, Hanne
    Cleal, Bryan
    Waeldchen, Mandy
    Lewis, Dana M.
    Gajewska, Katarzyna A.
    Skinner, Timothy C.
    Speight, Jane
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [48] Patient-Reported Outcomes of Adults with Type 1 Diabetes Using DoIt-Yourself Compared with Commercial Automated Insulin Delivery Systems
    Lebbar, Maha
    Wu, Zekai
    Bonhoure, Anne C.
    Messier, Virginie
    Brazeau, Anne-Sophie
    Rabasa-Lhoret, Remi
    DIABETES, 2023, 72
  • [49] Real-World Outcomes of Glucose Sensor Use in Type 1 Diabetes-Findings from a Large UK Centre
    Lee, Kyuhan
    Gunasinghe, Shakthi
    Chapman, Alyson
    Findlow, Lynne A.
    Hyland, Jody
    Ohol, Sheetal
    Urwin, Andrea
    Rutter, Martin K.
    Schofield, Jonathan
    Thabit, Hood
    Leelarathna, Lalantha
    BIOSENSORS-BASEL, 2021, 11 (11):
  • [50] Long-term glycaemic improvement with the initiation of an automated insulin delivery system in insulin pump-naïve older adults with type 1 diabetes
    Karakus, Kagan E.
    Mason, Emma
    Akturk, Halis K.
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 410 - 413